• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白酶体和半胱氨酸蛋白酶在MHC I类抗原呈递中的选择性参与。

Selective involvement of proteasomes and cysteine proteases in MHC class I antigen presentation.

作者信息

López D, Del Val M

机构信息

Centro Nacional de Biología Fundamental, Instituto de Salud Carlos III, Madrid, Spain.

出版信息

J Immunol. 1997 Dec 15;159(12):5769-72.

PMID:9550370
Abstract

CTL recognize peptides derived from protein Ags bound to MHC-class I molecules. Proteasomes probably participate in the generation of these peptide epitopes. We investigated the role of proteasomes in the presentation of endogenously synthesized short viral proteins. To this end, we employed proteasome and cysteine protease inhibitors and two closely related recombinant vaccinia viruses that code for 17- and 19-amino acid-long products encompassing murine CMV 9pp89 epitope. Presentation of both minigene products required processing to shorter peptides and was independent of ubiquitination. Proteasomes were necessary for processing the 17-mer product, and cysteine proteases were not required. In contrast, the 19-mer product could be processed in parallel either by proteasomes or by cysteine proteases independently. These results highlight the diversity of alternative processing pathways even for short peptidic Ags, provide evidence for the involvement of cysteine proteases in MHC class I presentation, and show that cleavage by cysteine proteases is governed by sequences flanking the epitope.

摘要

细胞毒性T淋巴细胞(CTL)识别与MHC-I类分子结合的蛋白质抗原衍生的肽段。蛋白酶体可能参与这些肽表位的产生。我们研究了蛋白酶体在呈现内源性合成的短病毒蛋白中的作用。为此,我们使用了蛋白酶体和半胱氨酸蛋白酶抑制剂以及两种密切相关的重组痘苗病毒,它们编码包含鼠巨细胞病毒9pp89表位的17和19个氨基酸长的产物。两种小基因产物的呈递都需要加工成更短的肽段,并且与泛素化无关。蛋白酶体对于加工17聚体产物是必需的,而不需要半胱氨酸蛋白酶。相反,19聚体产物可以由蛋白酶体或半胱氨酸蛋白酶独立地并行加工。这些结果突出了即使对于短肽抗原而言替代加工途径的多样性,为半胱氨酸蛋白酶参与MHC-I类呈递提供了证据,并表明半胱氨酸蛋白酶的切割受表位侧翼序列的支配。

相似文献

1
Selective involvement of proteasomes and cysteine proteases in MHC class I antigen presentation.蛋白酶体和半胱氨酸蛋白酶在MHC I类抗原呈递中的选择性参与。
J Immunol. 1997 Dec 15;159(12):5769-72.
2
Point mutation flanking a CTL epitope ablates in vitro and in vivo recognition of a full-length viral protein.位于细胞毒性T淋巴细胞(CTL)表位侧翼的点突变消除了对全长病毒蛋白的体外和体内识别。
J Immunol. 1997 Apr 1;158(7):3227-34.
3
The generation of MHC class I-associated peptides is only partially inhibited by proteasome inhibitors: involvement of nonproteasomal cytosolic proteases in antigen processing?蛋白酶体抑制剂仅部分抑制与MHC I类相关肽的产生:非蛋白酶体胞质蛋白酶参与抗原加工?
J Immunol. 1997 Jul 15;159(2):554-64.
4
Sequential cleavage by metallopeptidases and proteasomes is involved in processing HIV-1 ENV epitope for endogenous MHC class I antigen presentation.金属肽酶和蛋白酶体的顺序切割参与了HIV-1包膜蛋白表位的加工,以进行内源性MHC I类抗原呈递。
J Immunol. 2000 May 15;164(10):5070-7. doi: 10.4049/jimmunol.164.10.5070.
5
Novel dipeptide aldehydes are proteasome inhibitors and block the MHC-I antigen-processing pathway.新型二肽醛是蛋白酶体抑制剂,可阻断MHC-I抗原加工途径。
J Immunol. 1995 Aug 15;155(4):1767-75.
6
Dissociation of proteasomal degradation of biosynthesized viral proteins from generation of MHC class I-associated antigenic peptides.生物合成的病毒蛋白的蛋白酶体降解与MHC I类相关抗原肽生成的解离。
J Immunol. 1998 May 15;160(10):4859-68.
7
The proteasome-specific inhibitor lactacystin blocks presentation of cytotoxic T lymphocyte epitopes in human and murine cells.蛋白酶体特异性抑制剂乳胞素可阻断人和鼠细胞中细胞毒性T淋巴细胞表位的呈递。
Eur J Immunol. 1997 Jan;27(1):336-41. doi: 10.1002/eji.1830270148.
8
Proteasomes can either generate or destroy MHC class I epitopes: evidence for nonproteasomal epitope generation in the cytosol.蛋白酶体既能产生也能破坏MHC I类表位:胞质溶胶中存在非蛋白酶体表位产生的证据。
J Immunol. 1998 Jul 1;161(1):112-21.
9
The proteasome activator 11 S REG (PA28) and class I antigen presentation.蛋白酶体激活剂11S REG(PA28)与I类抗原呈递。
Biochem J. 2000 Jan 1;345 Pt 1(Pt 1):1-15.
10
Two new proteases in the MHC class I processing pathway.MHC I类加工途径中的两种新型蛋白酶。
Nat Immunol. 2000 Nov;1(5):413-8. doi: 10.1038/80852.

引用本文的文献

1
Variable processing and cross-presentation of HIV by dendritic cells and macrophages shapes CTL immunodominance and immune escape.树突状细胞和巨噬细胞对HIV的可变处理和交叉呈递塑造了CTL免疫显性和免疫逃逸。
PLoS Pathog. 2015 Mar 17;11(3):e1004725. doi: 10.1371/journal.ppat.1004725. eCollection 2015 Mar.
2
Feline degenerative joint disease: a genomic and proteomic approach.猫退行性关节病:一种基因组学和蛋白质组学方法。
J Feline Med Surg. 2013 Jun;15(6):466-77. doi: 10.1177/1098612X12470652. Epub 2013 Jan 7.
3
Caspases in virus-infected cells contribute to recognition by CD8+ T lymphocytes.
病毒感染细胞中的胱天蛋白酶有助于 CD8+ T 淋巴细胞的识别。
J Immunol. 2010 May 1;184(9):5193-9. doi: 10.4049/jimmunol.1000050. Epub 2010 Mar 26.
4
Targeting proteins to distinct subcellular compartments reveals unique requirements for MHC class I and II presentation.将蛋白质靶向不同的亚细胞区室揭示了MHC I类和II类呈递的独特要求。
Proc Natl Acad Sci U S A. 2009 Oct 13;106(41):17463-8. doi: 10.1073/pnas.0908583106. Epub 2009 Sep 25.
5
alpha v beta3-dependent cross-presentation of matrix metalloproteinase-2 by melanoma cells gives rise to a new tumor antigen.黑色素瘤细胞通过αvβ3依赖性交叉呈递基质金属蛋白酶-2产生一种新的肿瘤抗原。
J Exp Med. 2005 Jul 4;202(1):61-72. doi: 10.1084/jem.20042138.
6
Endogenous presentation of CD8+ T cell epitopes from Epstein-Barr virus-encoded nuclear antigen 1.来自爱泼斯坦-巴尔病毒编码核抗原1的CD8 + T细胞表位的内源性呈递
J Exp Med. 2004 May 17;199(10):1421-31. doi: 10.1084/jem.20040191.
7
Accelerated HER-2 degradation enhances ovarian tumor recognition by CTL. Implications for tumor immunogenicity.HER-2加速降解增强了CTL对卵巢肿瘤的识别。对肿瘤免疫原性的影响。
Mol Cell Biochem. 2001 Jan;217(1-2):21-33. doi: 10.1023/a:1007267814251.
8
Cytoplasmic processing is a prerequisite for presentation of an endogenous antigen by major histocompatibility complex class II proteins.胞质加工是内源性抗原通过主要组织相容性复合体II类蛋白呈递的前提条件。
J Exp Med. 2000 May 1;191(9):1513-24. doi: 10.1084/jem.191.9.1513.
9
Modulation of proteasomal activity required for the generation of a cytotoxic T lymphocyte-defined peptide derived from the tumor antigen MAGE-3.蛋白酶体活性的调节是产生源自肿瘤抗原MAGE-3的细胞毒性T淋巴细胞定义肽所必需的。
J Exp Med. 1999 Mar 15;189(6):895-906. doi: 10.1084/jem.189.6.895.
10
Major histocompatibility complex class I viral antigen processing in the secretory pathway defined by the trans-Golgi network protease furin.由反式高尔基体网络蛋白酶弗林蛋白酶定义的分泌途径中的主要组织相容性复合体I类病毒抗原加工。
J Exp Med. 1998 Sep 21;188(6):1105-16. doi: 10.1084/jem.188.6.1105.